Assuming Naders statement was true, I believe the FDA requested the data to get a jump start on analysis, but we still have to complete our analysis and request an EUA. They arent going to just give it to us.

I have no idea where we are at with any of this, I dont think any of us do.

With that said, if the data was bad, it would be known quickly. And, I assume they would discontinue the open label.

There are many possible reasons why we havent heard. I dont interoperate any of them as bad news.